Abstract
Antioxidant potential of some β-ionyl compounds has been assessed by examining their ability to protect methyl linoleate from aerial and 2,2-azobisisobutyronitrile-induced radical-mediated oxidation. It is observed that the π- electron density of β-ionyl structure is an important factor in the antiradical activity of these compounds.
Keywords: β-Ionone, retinoids, antiradical, antioxidants, radioprotectants, peroxidation, methyl linoleate, AIBN
Letters in Organic Chemistry
Title: Antiradical Activity of β-Ionyl Compounds
Volume: 7 Issue: 4
Author(s): Anil K. Singh and Solomon B. Libsu
Affiliation:
Keywords: β-Ionone, retinoids, antiradical, antioxidants, radioprotectants, peroxidation, methyl linoleate, AIBN
Abstract: Antioxidant potential of some β-ionyl compounds has been assessed by examining their ability to protect methyl linoleate from aerial and 2,2-azobisisobutyronitrile-induced radical-mediated oxidation. It is observed that the π- electron density of β-ionyl structure is an important factor in the antiradical activity of these compounds.
Export Options
About this article
Cite this article as:
K. Singh Anil and B. Libsu Solomon, Antiradical Activity of β-Ionyl Compounds, Letters in Organic Chemistry 2010; 7 (4) . https://dx.doi.org/10.2174/157017810791130603
DOI https://dx.doi.org/10.2174/157017810791130603 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Dual-Specificity MAP Kinase Phosphatases as Targets of Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry Plant Phenolic Compounds as Potential Lead Compounds in Functional Foods for Antiviral Drug Discovery
Current Organic Chemistry A Common Biological Mechanism in Cancer and Alzheimers Disease?
Current Alzheimer Research Phytoecdysteroids - From Isolation to Their Effects on Humans
Current Medicinal Chemistry Tumor Angiogenesis: A Potential Target In Cancer Control by Phytochemicals
Current Cancer Drug Targets Design of Novel Antitumor DNA Alkylating Agents: The Benzacronycine Series
Current Medicinal Chemistry - Anti-Cancer Agents Insertional Mutagenesis by Retroviral Vectors: Current Concepts and Methods of Analysis
Current Gene Therapy Clinical Application of Lentiviral Vectors – Concepts and Practice
Current Gene Therapy Drug Targets in Cytomegalovirus Infection
Infectious Disorders - Drug Targets Recent Advances in the Discovery of Novel HSP90 Inhibitors: An Update from 2014
Current Drug Targets Current Management of Vascular Tumors in the Neonate
Current Pediatric Reviews Functional Role of miR-34 Family in Human Cancer
Current Drug Targets Identification of Novel Antagonists for Rab38 Protein by Homology Modeling and Virtual Screening
Combinatorial Chemistry & High Throughput Screening Combined Treatment with PPAR-γ Agonists in Pancreatic Cancer: A Glimmer of Hope for Cancer Therapy?
Current Cancer Drug Targets Editorial: Frontier Views in Designing Therapeutic Candidates for Management of Diverse Diseases
Current Pharmaceutical Design Recent Developments in the Third Generation Inhibitors of Bcr-Abl for Overriding T315I Mutation
Current Medicinal Chemistry Status of Non-Classical Mononuclear Platinum Anticancer Drug Development
Mini-Reviews in Medicinal Chemistry Flavonoids Influence Epigenetic-Modifying Enzyme Activity: Structure-Function Relationships and the Therapeutic Potential for Cancer
Current Medicinal Chemistry Chemical Advances in Therapeutic Application of Exosomes and Liposomes
Current Medicinal Chemistry Glioma: Tryptophan Catabolite and Melatoninergic Pathways Link microRNA, 14-3- 3, Chromosome 4q35, Epigenetic Processes and other Glioma Biochemical Changes
Current Pharmaceutical Design